University Granted USD25 Million for Diabetic Stroke Study

Tue, 16 Aug 2011
The University of Virginia has been granted $25 million for breakthroughs for diabetic stroke patients.

The National Institutes of Health has given UVA this funding for a nationwide 50 centre clinical trial of a new treatment for acute stroke victims with high blood sugar or hyperglycaemia.

Those who are going to be eligible for this research are going to be hyperglycaemic acute stroke patients, who would almost all have diabetes.

Within 12 hours after a stroke, the new treatment gives patients an insulin IV for up to three days.

A stroke is considered to be critical for the first 12 hours; thereafter it is no longer considered acute. Therefore, it is essential to get to a hospital as soon you can for effective treatment.

For the purposes of this trial, it is essential that treatment is started within 12 hours of the first symptoms and within three hours of arrival at hospital.

The research is aiming to determine whether or not insulin treatments, once a person has had a stroke, are going to improve the effect of a stroke for patients with high blood sugar. Very high blood sugar increases the likelihood of stroke sufferers dying or becoming disabled by a stroke.

The research is seeking to determine whether or not insulin therapy can improve outcomes for those who do not have low blood sugar.

Link to this page

Copy and Paste the following HTML into your page.